| Literature DB >> 31151987 |
Shengjiang Tan1,2,3, Laëtitia Kermasson4,5, Angela Hoslin6, Pekka Jaako1,2,3, Alexandre Faille1,2,3, Abraham Acevedo-Arozena6,7,8,9, Etienne Lengline10, Dana Ranta11, Maryline Poirée12, Odile Fenneteau13, Hubert Ducou le Pointe14,15, Stefano Fumagalli16,17, Blandine Beaupain18, Patrick Nitschké19, Christine Bôle-Feysot20, Jean-Pierre de Villartay4,5, Christine Bellanné-Chantelot21, Jean Donadieu22, Caroline Kannengiesser23,24, Alan J Warren1,2,3, Patrick Revy4,5.
Abstract
Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in these individuals include impaired ribosomal subunit joining and attenuated global protein translation as a consequence of defective eIF6 eviction. In mice, Efl1 deficiency recapitulates key aspects of the SDS phenotype. By identifying biallelic EFL1 mutations in SDS, we define this leukemia predisposition disorder as a ribosomopathy that is caused by corruption of a fundamental, conserved mechanism, which licenses entry of the large ribosomal subunit into translation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31151987 PMCID: PMC6754720 DOI: 10.1182/blood.2018893404
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113